Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
GEN - Genetic Engineering and Biotechnology News59m
DeepMind Spinout Isomorphic Labs Raises $600M Toward AI Drug Design
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Crunchbase News1h
Alphabet-Backed Isomorphic Labs Raises $600M For AI Drug Development
Google spinoff Isomorphic Labs raised $600 million in its first external funding round as the company looks to apply ...
Pharmaceutical Technology2h
Google-backed Isomorphic Labs raises $600m to advance AI drug discovery
The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
Always Wanted a Personal Assistant? This AI Startup Wants to Help
Yutori wants to bring AI into the workplace by creating a digital personal assistant that can actually do some work for you ...
Google DeepMind’s drug discovery spin-off Isomorphic Labs raises $600mn
Isomorphic Labs, the drug discovery start-up spun out of Google’s DeepMind artificial intelligence unit, has raised $600mn in its first external funding round, as investors bet on the potential for AI ...
Fierce Biotech4h
Alphabet's AI biotech Isomorphic Labs hauls in $600M to power next-gen drug design model
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
pharmaphorum5h
Alphabet's Isomorphic raises $600m for AI drug discovery
Lilly and Novartis have collectively pledged almost $3 billion to their partnerships with Isomorphic signed last year, which ...
Isomorphic raises $600M on big ambitions for AI drugmaking tech
The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...
Alphabet-backed Isomorphic Labs bags $600 million funding to build next-gen AI drug design engine
Isomorphic Labs is raising money in its first-ever external funding round from Thrive Capital, a big backer of ChatGPT ...